Han A C, Peralta-Soler A, Knudsen K A, Wheelock M J, Johnson K R, Salazar H
Department of Pathology, the Reading Hospital and Medical Center, West Reading, PA 19612, USA.
Hum Pathol. 1997 Jun;28(6):641-5. doi: 10.1016/s0046-8177(97)90171-4.
The differential diagnosis of pleural mesotheliomas and lung adenocarcinomas presents a continued challenge in the practice of surgical pathology. Paraffin immunohistochemistry (IHC) using different panels of antibodies can be helpful in some cases, but, as yet, no antigen is expressed specifically in mesotheliomas nor in adenocarcinomas. Using well characterized monoclonal antibodies (MAb) that recognized distinct mesenchymal and epithelial adhesion proteins, N-cadherin (13A9 MAb) and E-cadherin (E9 MAb), respectively, we found previously that in frozen-section IHC mesotheliomas and adenocarcinomas had distinct cadherin phenotypes: mesotheliomas were positive for N-cadherin, and lung adenocarcinomas were positive for E-cadherin. Using antigen-retrieval methods, we successfully extended our study to formalin-fixed, paraffin-embedded tissue sections. Tumors from 28 patients (14 originally diagnosed as mesotheliomas, and 14 diagnosed as adenocarcinomas) were stained with 13A9 MAb and E9 MAb. Review of hematoxylin-eosin sections excluded from analysis one case previously diagnosed as mesothelioma, which represented a hemangiopericytoma. Of the remaining 27 cases, 12 of 13 mesotheliomas were positive for N-cadherin and negative for E-cadherin. The exception was a multifocal microscopic papillary tumor of apparent mesothelial origin, which was negative for both N-cadherin and E-cadherin. Conversely, 13 of 14 adenocarcinomas were E-cadherin positive and N-cadherin negative except for one adenocarcinoma with focal N-cadherin expression. One case of a poorly differentiated adenocarcinoma invading skeletal muscle was negative for both 13A9 and E9. These studies confirmed the utility of the cadherin antibodies in distinguishing pleural mesotheliomas from lung adenocarcinomas. The reactivity of the cadherin-specific antibodies with antigens in paraffin sections make them powerful and reliable markers in the practice of diagnostic surgical pathology.
在外科病理学实践中,胸膜间皮瘤和肺腺癌的鉴别诊断一直是一项挑战。使用不同抗体组合的石蜡免疫组织化学(IHC)在某些情况下可能会有所帮助,但到目前为止,尚未发现有抗原在间皮瘤或腺癌中特异性表达。我们先前使用分别识别不同间充质和上皮粘附蛋白的特征明确的单克隆抗体(MAb),即N-钙粘蛋白(13A9 MAb)和E-钙粘蛋白(E9 MAb),发现在冰冻切片IHC中,间皮瘤和腺癌具有不同的钙粘蛋白表型:间皮瘤N-钙粘蛋白呈阳性,肺腺癌E-钙粘蛋白呈阳性。通过抗原修复方法,我们成功地将研究扩展到福尔马林固定、石蜡包埋的组织切片。对28例患者的肿瘤(14例最初诊断为间皮瘤,14例诊断为腺癌)用13A9 MAb和E9 MAb进行染色。苏木精-伊红切片复查排除了1例先前诊断为间皮瘤的病例进行分析,该病例实为血管外皮细胞瘤。在其余27例病例中,13例间皮瘤中有12例N-钙粘蛋白呈阳性,E-钙粘蛋白呈阴性。例外的是1例明显起源于间皮的多灶性微小乳头状肿瘤,N-钙粘蛋白和E-钙粘蛋白均为阴性。相反,14例腺癌中有13例E-钙粘蛋白呈阳性,N-钙粘蛋白呈阴性,只有1例腺癌有局灶性N-钙粘蛋白表达。1例侵犯骨骼肌的低分化腺癌13A9和E9均为阴性。这些研究证实了钙粘蛋白抗体在鉴别胸膜间皮瘤和肺腺癌方面的实用性。钙粘蛋白特异性抗体与石蜡切片中抗原的反应性使其成为诊断外科病理学实践中强大而可靠的标志物。